📣 Join us at the Obesity Medicine 2026 Conference • April 10-12 • Booth #201

Media & press

Latest

Article

Phenomix Sciences Expands Evidence for MyPhenome™ Test Predicting GLP-1 Response and Obesity Risk in Large, Diverse Populations

Menlo Park, Calif.

November 4, 2025

Studies presented at Obesity Week 2025 validate the test’s ability to predict weight-loss response to GLP-1 drugs like semaglutide, including in diverse patient populations and post-bariatric surgery patients.

Read article

No items found.